The association between metabolic syndrome (MetS) and the risk of osteoarthritis (OA).
GSK pulls plans to market anemia drug in EU and other markets, citing ‘reduced opportunity’
It appears GSK’s Jesduvroq will not launch in new markets for now, with the pharma giant withdrawing its bid to market the anemia drug in